Literature DB >> 25683949

Irisin as an exercise-stimulated hormone binding crosstalk between organs.

J Liu1.   

Abstract

Irisin is a newly discovered 112 amino acid residues' glycosylated protein hormone that was firstly found up-regulated by exercise-induced peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) and then play an important role in circulation so as to target other organs. It conducts many downstream events including osteoblast differentiation, nerve cell and β-cell regeneration and so on. In clinical research, non-inflammation and inflammation related diseases correlated with basal level of irisin and they benefited from exercise-induced irisin endocrinology.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25683949

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN： 1128-3602            Impact factor:   3.507


  7 in total

Review 1.  Physical Activity and Post-Transcriptional Regulation of Aging Decay: Modulation of Pathways in Postmenopausal Osteoporosis.

Authors:  Federica Vita; Sebastiano Gangemi; Giovanni Pioggia; Fabio Trimarchi; Debora Di Mauro
Journal:  Medicina (Kaunas)       Date:  2022-06-06       Impact factor: 2.948

2.  The Effect of n-3 Polyunsaturated Fatty Acids Supplementation on Serum Irisin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Samaneh Ansari; Mahmoud Djalali; Niyaz Mohammadzadeh Honarvar; Maryam Mazaherioun; Mahnaz Zarei; Fahimeh Agh; Zahra Gholampour; Mohammad Hassan Javanbakht
Journal:  Int J Endocrinol Metab       Date:  2017-01-21

3.  Studies on the effects of hypothermia combined with hypoxia on rat skeletal muscle and lipid metabolism based on AMPK/PGC1α pathway.

Authors:  Zhang Ruixia; Liu Chuanchuan; Guan Lu; Ma Shuang; Zhu Qiang; Tian Xiaofang; Ba Yinggui
Journal:  J Orthop Surg Res       Date:  2021-12-07       Impact factor: 2.359

4.  Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways.

Authors:  Xiaoyong Qiao; Xiao Yong Qiao; Ying Nie; Yaxian Ma; Ya Xian Ma; Yan Chen; Ran Cheng; Weiyao Yin; Wei Yao Yinrg; Ying Hu; Wenming Xu; Wen Ming Xu; Liangzhi Xu; Liang Zhi Xu
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

Review 5.  Review of Research on the Role of Irisin in Tumors.

Authors:  Zengyin Chen; Guangjun Shi; Deguo Zhang; Xueying Tan; Nan Tang; Fei Huang
Journal:  Onco Targets Ther       Date:  2020-05-19       Impact factor: 4.147

6.  Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid β production in Alzheimer's disease.

Authors:  Yasuha Noda; Akira Kuzuya; Kyousuke Tanigawa; Mitsugu Araki; Ryoko Kawai; Biao Ma; Yoko Sasakura; Masato Maesako; Yoshitaka Tashiro; Masakazu Miyamoto; Kengo Uemura; Yasushi Okuno; Ayae Kinoshita
Journal:  Mol Brain       Date:  2018-10-24       Impact factor: 4.041

7.  Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health.

Authors:  Elena Dozio; Elena Vianello; Clementina Sitzia; Federico Ambrogi; Stefano Benedini; Silvia Gorini; Benedetta Rampoldi; Roberta Rigolini; Lorenza Tacchini; Massimiliano Marco Corsi Romanelli
Journal:  J Clin Med       Date:  2020-02-06       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.